Literature DB >> 8542168

Inflammatory cell populations in bronchial biopsies from aspirin-sensitive asthmatic subjects.

S M Nasser1, R Pfister, P E Christie, A R Sousa, J Barker, M Schmitz-Schumann, T H Lee.   

Abstract

The inflammatory cell infiltrate in bronchial biopsies of 12 aspirin-sensitive asthmatic (ASA) subjects and eight non-aspirin-sensitive (non-ASA) control subjects have been compared. Biopsies were taken from a right middle or lower lobe segmental carina using fiberoptic bronchoscopy. The biopsies were snap-frozen in OCT, and sections 5 microns thick were doubled immunostained using a rabbit polyclonal antibody to the enzyme 5-lipoxygenase (5-LO) and with a monoclonal antibody to neutrophils (NP57), macrophages (EMB11), and total (BMK13) and activated eosinophils (EG2), mast cells (AA1), and T-lymphocytes (anti-CD3). There was no significant difference in the total numbers of cells staining for 5-LO between the two groups of subjects. As a percentage of total 5-LO cells, there were significantly more mast cells (12.9 +/- 3.8% versus 3.4 +/- 3.1%; p = 0.039) and total eosinophils (34.7 +/- 9.4% versus 11.1 +/- 3.8%; p = 0.044) and significantly fewer macrophages (23.3 +/- 6.1% versus 39.8% +/- 5.3; p = 0.041) in the bronchial biopsies from ASA subjects as compared with non-ASA patients. The numbers of neutrophils, T-lymphocytes, and activated eosinophils were similar for the two groups. The increased numbers of eosinophils and mast cells identified in the bronchial tissue from aspirin-sensitive asthmatic subjects may be the source of the enhanced cysteinyl leukotriene production observed in these subjects.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8542168     DOI: 10.1164/ajrccm.153.1.8542168

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  26 in total

Review 1.  Genetics of aspirin induced asthma.

Authors:  M Sanak; A Szczeklik
Journal:  Thorax       Date:  2000-10       Impact factor: 9.139

Review 2.  Variability of inflammatory cell counts on bronchial biopsies of normal subjects.

Authors:  H Turcotte; M Laviolette; M Boutet; L-P Boulet
Journal:  Lung       Date:  2003       Impact factor: 2.584

3.  Overexpression of leukotriene C4 synthase in bronchial biopsies from patients with aspirin-intolerant asthma.

Authors:  A S Cowburn; K Sladek; J Soja; L Adamek; E Nizankowska; A Szczeklik; B K Lam; J F Penrose; F K Austen; S T Holgate; A P Sampson
Journal:  J Clin Invest       Date:  1998-02-15       Impact factor: 14.808

4.  Intranasal challenge with aspirin in the diagnosis of aspirin intolerant asthma: evaluation of nasal response by acoustic rhinometry.

Authors:  J Casadevall; P J Ventura; J Mullol; C Picado
Journal:  Thorax       Date:  2000-11       Impact factor: 9.139

5.  Type 2 Cysteinyl Leukotriene Receptors Drive IL-33-Dependent Type 2 Immunopathology and Aspirin Sensitivity.

Authors:  Tao Liu; Nora A Barrett; Yoshihide Kanaoka; Eri Yoshimoto; Denise Garofalo; Haley Cirka; Chunli Feng; Joshua A Boyce
Journal:  J Immunol       Date:  2017-12-27       Impact factor: 5.422

Review 6.  Aspirin-induced asthma: clinical aspects, pathogenesis and management.

Authors:  Ahmed M Hamad; Amy M Sutcliffe; Alan J Knox
Journal:  Drugs       Date:  2004       Impact factor: 9.546

7.  Protection of leukotriene receptor antagonist against aspirin-induced bronchospasm in asthmatics.

Authors:  Jong Sook Park; An Soo Jang; Sung Woo Park; Young Mok Lee; Soo Taek Uh; Yong Hoon Kim; Ji Yean Cha; Se Min Park; Choon-Sik Park
Journal:  Allergy Asthma Immunol Res       Date:  2009-12-30       Impact factor: 5.764

8.  IL-13 Gene Polymorphisms are Associated With Rhinosinusitis and Eosinophilic Inflammation in Aspirin Intolerant Asthma.

Authors:  Nami Shrestha Palikhe; Seung-Hyun Kim; Bo-Young Cho; Gil-Soon Choi; Joo-Hee Kim; Young-Min Ye; Hae-Sim Park
Journal:  Allergy Asthma Immunol Res       Date:  2010-03-24       Impact factor: 5.764

9.  Aspirin-exacerbated asthma.

Authors:  Mathew Varghese; Richard F Lockey
Journal:  Allergy Asthma Clin Immunol       Date:  2008-06-15       Impact factor: 3.406

10.  Cytokine expression before and after aspirin desensitization therapy in aspirin-exacerbated respiratory disease.

Authors:  Ayse Aktas; Emel Kurt; Zafer Gulbas
Journal:  Inflammation       Date:  2013-12       Impact factor: 4.092

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.